January 13, 2020


Chile's SERNAPESCA presents new certification programme to optimise antimicrobial use in salmon farming


The National Fisheries and Aquaculture Service, SERNAPESCA presented in Puerto Varas the new Program for the Optimization of the Use of Antimicrobials in Salmon Farming, PROA / Salmon. The initiative seeks to maintain good results in the progressive decrease in the use of these treatments in Chilean salmon production.



This was highlighted by the deputy director of Aquaculture of SERNAPESCA, Marcela Lara, at the seminar "Antimicrobials in National Salmoniculture: improving practices for the optimization of its use", which was attended by the main salmon producers in the country. During her presentation, she highlighted that during the first half of 2019 there was a 6% decrease in the use of antimicrobials compared to the previous year, which adds to the good results obtained in previous years. "In the last five years, we have a total decrease close to 45%," she said.


Lara explained that the reduction is the result of the implementation of various measures, such as the Online System of Veterinary Medical Prescriptions, the Free Certification for the Use of Antimicrobials, the Manual of Good Practices, and especially the increase in the transparency of information, a factor that in the opinion of the authority is essential for proper management and efficient use of these products.


Despite the good results, Lara indicated that there is still room to continue making these treatments more efficient, and for this the institution presented its new voluntary PROA certification programme, which was designed based on the recommendations generated by the Program for the Health Management of Aquaculture (PGSA), as well as experiences of the industry itself.


PROA is an official voluntary certification that will be granted to each farming centre participating in the programme. Its objectives are to promote awareness in the use of antimicrobials, boost good practices and disseminate health management recommendations based on PGSA research.


Source: www.fis.com